GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » Investments And Advances

AbbVie (BSP:ABBV34) Investments And Advances : R$1,519 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is AbbVie Investments And Advances?

AbbVie's Investments And Advances for the quarter that ended in Mar. 2024 was R$1,519 Mil.

AbbVie's quarterly Investments And Advances increased from Sep. 2023 (R$1,358 Mil) to Dec. 2023 (R$1,490 Mil) and increased from Dec. 2023 (R$1,490 Mil) to Mar. 2024 (R$1,519 Mil).

AbbVie's annual Investments And Advances declined from Dec. 2021 (R$1,566 Mil) to Dec. 2022 (R$1,264 Mil) but then increased from Dec. 2022 (R$1,264 Mil) to Dec. 2023 (R$1,490 Mil).


AbbVie Investments And Advances Historical Data

The historical data trend for AbbVie's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Investments And Advances Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 381.72 1,507.40 1,566.41 1,264.14 1,489.54

AbbVie Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,338.61 1,397.87 1,358.14 1,489.54 1,518.84

AbbVie Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


AbbVie (BSP:ABBV34) Business Description

Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (BSP:ABBV34) Headlines

No Headlines